BioSpace News Archive

First patient receives ImmunityBio’s second-generation hAd5 COVID vaccine, delivering both outer S (spike) protein and inner N (nucleocapsid) leading to potential long-term T cell and antibody immunity to the SARS-CoV-2 virus

Encouraging clinical results from TACTI-002 and INSIGHT-004 trials of eftilagimod alpha completed recruitment for Stage 1 of Part B in TACTI-002 Study Granted United States patent relating to eftilagimod alpha and LAG525

In response to the pharmaceutical giant Mallinckrodt’s bankruptcy filing last week, Delaware Valley Health Care Coalition, Inc. (DVHCC) President John Heenan said, “Its crucial for our members to have a seat at the table for the bankruptcy proceedings.” The DVHCC is a non-profit voluntary association comprised of multi-employer trust funds, governmental entities, labor unions, schools and school districts in ov

The rapid increase in lifestyle ailments, rising expenses of healthcare, and increasing number of elderly population have incited various medical insurance organizations and healthcare sector to innovate.

The growing need for minimizing errors and convenience in clinical medication and adequate knowledge of prescribed dose is likely to bolster growth of the global polymer-based prefilled syringe market in the years to come.

Oligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers.

Medical Transcription comprises software and services in the medical sector. These services comprise a wide range of activities and reports, such as consultation reports, operative notes, discharge summary, and physical and history reports.

SparingVision (“the Company”), a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round.